• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Drug-coated balloons on the "big stage": is this technology ready for an all-comer population with de novo lesions?].

作者信息

Wan Ha Wojciech, Iwan Czyk Sylwia, Cortese Bernardo

机构信息

Department of Cardiology and Structural Heart Diseases, Medical University of Silesia, Katowice, Polonia Department of Cardiology and Structural Heart Diseases Medical University of Silesia Katowice Polonia.

DCB Academy, Milano, Italia DCB Academy DCB Academy Milano Italia.

出版信息

REC Interv Cardiol. 2024 Apr 8;6(4):266-268. doi: 10.24875/RECIC.M23000439. eCollection 2024 Oct-Dec.

DOI:10.24875/RECIC.M23000439
PMID:40417344
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12097340/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f049/12097340/d0cbda70c7d3/2604-7306-recic-6-4-266-gf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f049/12097340/179d9fd2df67/2604-7306-recic-6-4-266-en-gf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f049/12097340/d0cbda70c7d3/2604-7306-recic-6-4-266-gf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f049/12097340/179d9fd2df67/2604-7306-recic-6-4-266-en-gf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f049/12097340/d0cbda70c7d3/2604-7306-recic-6-4-266-gf1.jpg

相似文献

1
[Drug-coated balloons on the "big stage": is this technology ready for an all-comer population with de novo lesions?].[药物涂层球囊登上“大舞台”：这项技术是否已准备好应用于所有新发病变患者群体？]
REC Interv Cardiol. 2024 Apr 8;6(4):266-268. doi: 10.24875/RECIC.M23000439. eCollection 2024 Oct-Dec.
2
Drug-coated balloons for treating lesions in large coronary vessels: A case report.用于治疗大型冠状动脉血管病变的药物涂层球囊：一例病例报告。
World J Clin Cases. 2023 Jul 16;11(20):4920-4925. doi: 10.12998/wjcc.v11.i20.4920.
3
Which predilatation balloons provide the best lesion preparation prior to use of drug coated balloons in de-novo lesions? Results from the PREPARE study.在初次病变中使用药物涂层球囊前，哪种预扩张球囊能提供最佳的病变准备？来自 PREPARE 研究的结果。
Minerva Cardiol Angiol. 2023 Apr;71(2):182-188. doi: 10.23736/S2724-5683.22.05989-0. Epub 2022 Apr 14.
4
Drug-coated balloons for de novo lesions in small coronary arteries: rationale and design of BASKET-SMALL 2.用于小冠状动脉初发病变的药物涂层球囊：BASKET-SMALL 2研究的原理与设计
Clin Cardiol. 2018 May;41(5):569-575. doi: 10.1002/clc.22942. Epub 2018 May 10.
5
Drug-coated Balloons for De Novo Lesions in Large Coronary Arteries-Are They Ready for Prime Time?用于大型冠状动脉初发病变的药物涂层球囊——它们准备好进入黄金时代了吗？
Cardiovasc Drugs Ther. 2025 May 22. doi: 10.1007/s10557-025-07719-9.
6
Long-Term Follow-Up After Treatment of Drug-Eluting Stent Restenosis and De Novo Lesions Using SeQuent Please Paclitaxel-Coated Balloons.使用SeQuent Please紫杉醇涂层球囊治疗药物洗脱支架再狭窄和新发病变后的长期随访
Angiology. 2019 May;70(5):414-422. doi: 10.1177/0003319718809423. Epub 2018 Nov 1.
7
Long term outcome after treatment of de novo coronary artery lesions using three different drug coated balloons.三种不同药物涂层球囊治疗新发冠状动脉病变的长期结果。
Int J Cardiol. 2021 Feb 15;325:30-36. doi: 10.1016/j.ijcard.2020.09.054. Epub 2020 Sep 25.
8
Late clinical outcomes for SeQuent please paclitaxel-coated balloons in PCI of instent restenosis and de novo lesions: A single-center, real world registry.SeQuent please紫杉醇涂层球囊用于支架内再狭窄和原发病变经皮冠状动脉介入治疗的晚期临床结果：一项单中心、真实世界注册研究。
Catheter Cardiovasc Interv. 2017 Feb 15;89(3):375-382. doi: 10.1002/ccd.26546. Epub 2016 Apr 26.
9
Sirolimus-Coated Balloon in an All-Comer Population of Coronary Artery Disease Patients: The EASTBOURNE Prospective Registry.西罗莫司涂层球囊在所有冠心病患者中的应用：EASTBOURNE 前瞻性注册研究。
JACC Cardiovasc Interv. 2023 Jul 24;16(14):1794-1803. doi: 10.1016/j.jcin.2023.05.005.
10
12-Month clinical results of drug-coated balloons for de novo coronary lesion in vessels exceeding 3.0 mm.药物涂层球囊治疗直径超过3.0毫米的冠状动脉初发病变的12个月临床结果。
Int J Cardiovasc Imaging. 2019 Apr;35(4):579-586. doi: 10.1007/s10554-018-1505-z. Epub 2019 Mar 30.

引用本文的文献

1
Drug-Coated Balloons: Recent Evidence and Upcoming Novelties.药物涂层球囊：近期证据与即将出现的新进展
J Cardiovasc Dev Dis. 2025 May 20;12(5):194. doi: 10.3390/jcdd12050194.

本文引用的文献

1
The fate of coronary dissections left after sirolimus-coated balloon angioplasty: A prespecified subanalysis of the EASTBOURNE study.西罗莫司涂层球囊血管成形术后遗留的冠状动脉夹层的命运：EASTBOURNE 研究的预先指定亚分析。
Catheter Cardiovasc Interv. 2023 Nov;102(6):979-986. doi: 10.1002/ccd.30906. Epub 2023 Nov 8.
2
The evolution and revolution of drug coated balloons in coronary angioplasty: An up-to-date review of literature data.药物涂层球囊在冠状动脉血管成形术中的演变和革新：文献资料的最新综述。
Catheter Cardiovasc Interv. 2023 Nov;102(6):1069-1077. doi: 10.1002/ccd.30891. Epub 2023 Oct 23.
3
Sirolimus-Coated Balloon in an All-Comer Population of Coronary Artery Disease Patients: The EASTBOURNE Prospective Registry.
西罗莫司涂层球囊在所有冠心病患者中的应用：EASTBOURNE 前瞻性注册研究。
JACC Cardiovasc Interv. 2023 Jul 24;16(14):1794-1803. doi: 10.1016/j.jcin.2023.05.005.
4
Long-Term Outcome of Drug-Coated Balloon vs Drug-Eluting Stent for Small Coronary Vessels: PICCOLETO-II 3-Year Follow-Up.药物涂层球囊与药物洗脱支架治疗小冠状动脉：PICCOLETO-II 研究 3 年随访结果。
JACC Cardiovasc Interv. 2023 May 8;16(9):1054-1061. doi: 10.1016/j.jcin.2023.02.011. Epub 2023 Apr 19.
5
Sirolimus-coated balloon versus everolimus-eluting stent in de novo coronary artery disease: Rationale and design of the TRANSFORM II randomized clinical trial.西罗莫司涂层球囊与依维莫司洗脱支架治疗初发冠状动脉疾病：TRANSFORM II 随机临床试验的原理和设计。
Catheter Cardiovasc Interv. 2022 Oct;100(4):544-552. doi: 10.1002/ccd.30358. Epub 2022 Sep 2.
6
Long-Term Outcomes Following Drug-Eluting Balloons Versus Thin-Strut Drug-Eluting Stents for Treatment of In-Stent Restenosis (DEB-Dragon-Registry).药物涂层球囊与药物洗脱支架治疗支架内再狭窄的长期结果（DEB-Dragon-Registry）。
Circ Cardiovasc Interv. 2021 Sep;14(9):e010868. doi: 10.1161/CIRCINTERVENTIONS.121.010868. Epub 2021 Sep 3.
7
10-Year Follow-Up of Patients With Everolimus-Eluting Versus Bare-Metal Stents After ST-Segment Elevation Myocardial Infarction.ST 段抬高型心肌梗死患者采用依维莫司洗脱支架与裸金属支架 10 年随访结果。
J Am Coll Cardiol. 2021 Mar 9;77(9):1165-1178. doi: 10.1016/j.jacc.2020.12.059.
8
Drug-Coated Balloon Versus Drug-Eluting Stent for Small Coronary Vessel Disease: PICCOLETO II Randomized Clinical Trial.药物涂层球囊与药物洗脱支架治疗小血管病变的冠状动脉疾病：PICCOLETO II 随机临床试验。
JACC Cardiovasc Interv. 2020 Dec 28;13(24):2840-2849. doi: 10.1016/j.jcin.2020.08.035. Epub 2020 Nov 25.
9
A Prospective Multicenter Randomized Trial to Assess the Effectiveness of the MagicTouch Sirolimus-Coated Balloon in Small Vessels: Rationale and Design of the TRANSFORM I Trial.一项评估 MagicTouch 西罗莫司涂层球囊在小血管中有效性的前瞻性多中心随机试验：TRANSFORM I 试验的原理和设计。
Cardiovasc Revasc Med. 2021 Apr;25:29-35. doi: 10.1016/j.carrev.2020.10.004. Epub 2020 Oct 17.
10
Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial.药物涂层球囊与药物洗脱支架治疗小冠状动脉疾病的长期疗效和安全性（BASKET-SMALL 2）：一项随机、非劣效性试验的 3 年随访结果。
Lancet. 2020 Nov 7;396(10261):1504-1510. doi: 10.1016/S0140-6736(20)32173-5. Epub 2020 Oct 19.